Research Highlights

< Previous         Next >  
A new avenue to cure cancer by turning adaptive immune T cells to innate immune NK cells via reprogramming Free
Dong-Ming Su 1,* and Ramakrishna Vankayalapati2
1Department of Biomedical Research, University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA
2Center for Pulmonary and Infectious Disease Control, University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA *Correspondence to:Dong-Ming Su, Tel: +1-903-877-7587; Fax: +1-903-877-7968; E-mail: dong-ming.su@uthct.edu
J Mol Cell Biol, Volume 2, Issue 5, October 2010, 237-239,  https://doi.org/10.1093/jmcb/mjq016

Thymocytes after T-lineage commitment develop in the T-cell pathway. However, in a recent study, Li et al. (2010) demonstrated that inducing to delete Bcl11b gene in these thymocytes, even in mature T cells turns these cells into natural killer (NK) cells during the culture. They called this conversion 'reprogramming' and the reprogrammed killer cells 'ITNK cells'. The ITNK cells possessed tumor-killer ability and did not indiscriminately kill normal cells. This exciting finding represents a major breakthrough towards curing cancer and identifies an important, novel transcription factor in the thymus development.